CD4+ T-cells in the COVID-19 group also had higher expression levels of the activation markers OX40 and CD69, as well as the chemokine receptors CCR6 and CCR4, than the other respiratory infection group, implying a stronger activation (Figure 3d; Supplementary Figure S2). The gene discussed is CCR6; the disease is respiratory tract infectious disorder.